AI Revolutionizes Pregnancy Dating: FDA Clears Ultrasound AI for Precise Delivery Predictions

The U.S. Food and Drug Administration (FDA) has granted De Novo clearance to Ultrasound AI for its innovative Delivery Date AI technology. This cloud-based software utilizes artificial intelligence to predict a baby’s due date with remarkable accuracy, analyzing standard ultrasound images. This advancement promises to enhance clinical decision-making in maternal-fetal medicine and offers a significant leap forward from traditional dating methods.

Key Takeaways

• FDA De Novo clearance granted to Ultrasound AI for its Delivery Date AI technology.
• The AI predicts delivery dates using only standard ultrasound images, analyzing deep-learning neural networks.
• Technology aims to improve accuracy and reduce uncertainty in pregnancy dating, especially when traditional methods are unreliable.
• Validated by the PAIR study, demonstrating high predictive accuracy.
• Designed for seamless integration into existing clinical workflows.

A New Era in Pregnancy Dating

Ultrasound AI’s Delivery Date AI represents a significant advancement in obstetrics, offering a more precise method for predicting a delivery date (PDD). Unlike traditional approaches that rely on factors like the last menstrual period or standard ultrasound measurements, this AI analyzes entire ultrasound images. This "image-first" approach is trained on millions of images, allowing the deep-learning neural networks to identify subtle patterns that contribute to accurate dating.

Clinical Validation and Accuracy

The efficacy of the Delivery Date AI was rigorously tested in the Perinatal Artificial Intelligence in Ultrasound (PAIR) study. This research, conducted in collaboration with the University of Kentucky and published in The Journal of Maternal-Fetal & Neonatal Medicine, demonstrated the AI’s impressive predictive capabilities. Through iterative retraining on a vast dataset, the AI achieved an R2 value of 0.92, indicating a high level of accuracy in predicting delivery timing. This is a substantial improvement over traditional markers, which often suffer from lower sensitivity and predictive value.

Addressing Preterm Birth and Clinical Uncertainty

Approximately 10% of pregnancies in the United States, totaling around 380,000 annually, result in preterm birth, a leading cause of neonatal mortality. The Delivery Date AI’s enhanced predictive accuracy can provide clinicians with crucial insights, potentially enabling earlier interventions and improved management strategies for high-risk pregnancies. By offering an objective data point, the technology aims to reduce the clinical uncertainty that often complicates care, particularly in cases where pregnancy dating is otherwise unreliable.

Seamless Workflow Integration

Ultrasound AI has emphasized that the Delivery Date AI is designed to integrate smoothly into existing obstetrics and maternal-fetal medicine workflows. Clinicians can upload standard ultrasound images to a HIPAA-compliant portal, and the software returns a predicted delivery date in less than a minute. This minimal disruption to current practices makes the technology easily adoptable and scalable, even for resource-constrained clinics or areas with limited access to specialized expertise.

Unbiased Predictions

A key advantage of the Delivery Date AI is its unbiased approach. The AI is trained solely on ultrasound images, meaning it does not consider maternal characteristics such as age, weight, or tobacco use, which can influence traditional predictions. This image-only analysis ensures that the PDD serves as an objective measure, free from potential biases, thereby supporting more informed clinical decision-making.

Sources

• Raquel Dardik, MD, explains Ultrasound AI’s FDA-cleared delivery date technology, Contemporary OB/GYN.
• Ultrasound AI receives De Novo clearance for predictive delivery date technology, Contemporary OB/GYN.
• Using Ultrasound AI’s FDA-cleared predictive delivery date technology, Contemporary OB/GYN.

IntelligentHQ

Founder Dinis Guarda

IntelligentHQ Your New Business Network.

IntelligentHQ is a Business network and an expert source for finance, capital markets and intelligence for thousands of global business professionals, startups, and companies.

We exist at the point of intersection between technology, social media, finance and innovation.

IntelligentHQ leverages innovation and scale of social digital technology, analytics, news, and distribution to create an unparalleled, full digital medium and social business networks spectrum.

IntelligentHQ is working hard, to become a trusted, and indispensable source of business news and analytics, within financial services and its associated supply chains and ecosystems